Table 2 Univariate and multivariate analysis of overall survival of patients with gastric cancer
factor | Univariate analysis | P value | Multivaliate analysis | P value |
|---|---|---|---|---|
HR(95%CI) | Â | HR(95%CI) | Â | |
histology | ||||
undifferentiated vs differentiated | 1.805(1.138-2.933) | 0.011 | 2.155(1.084-4.540) | 0.028 |
pT Stage | ||||
III + IV vs I + II | 5.546(3.334-9.633) | < 0.001 | – | – |
pN Stage | ||||
(+) vs (−) | 4.129(2.500-7.092) | < 0.001 | – | – |
pStage | ||||
III + IVvsI+II | 5.124(3.193-8.355) | < 0.001 | 3.116(1.330-7.977) | 0.008 |
lymphatic invasion | ||||
present vs absent | 3.882(2.228-7.251) | < 0.001 | 0.594(0.151-2.218) | 0.443 |
venous invasion | ||||
present vs absent | 1.469(0.836-2.460) | 0.173 | – | – |
CD15 + TANs (primary) | ||||
high vs low | 2.157(1.081-4.588) | 0.028 | 1.391(0.676-3.038) | 0.376 |
CD15 + TANs (lymph) | ||||
high vs low | 2.150(1.122-4.278) | 0.013 | 1.997(1.036-4.051) | 0.038 |